Zoetis Inc. (NYSE: ZTS) stock jumped 0.41% on Thursday to $182.74 against a previous-day closing price of $182.00. With 2.0 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.84 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $183.91 whereas the lowest price it dropped to was $180.58. The 52-week range on ZTS shows that it touched its highest point at $194.99 and its lowest point at $124.15 during that stretch. It currently has a 1-year price target of $221.23. With its current market cap of 85.02 billion, ZTS has annualized dividend of $1.50 while the current yield stands at 0.82%. Beta for the stock currently stands at 0.78.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ZTS was down-trending over the past week, with a drop of -2.68%, but this was down by -3.39% over a month. Three-month performance surged to 10.32% while six-month performance rose 11.72%. The stock gained 13.51% in the past year, while it has gained 24.69% so far this year. A look at the trailing 12-month EPS for ZTS yields 4.75 with Next year EPS estimates of 6.09. For the next quarter, that number is 1.37. This implies an EPS growth rate of 5.20% for this year and 11.89% for next year. EPS is expected to grow by 10.53% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 15.50%.
Float and Shares Shorts:
At present, 461.90 million ZTS shares are outstanding with a float of 459.38 million shares on hand for trading. On Aug 30, 2023, short shares totaled 3.69 million, which was 0.80% higher than short shares on Jul 30, 2023. In addition to Ms. Kristin C. Peck as the firm’s CEO & Director, Mr. Wetteny N. Joseph serves as its Exec. VP & CFO.
Through their ownership of 94.62% of ZTS’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 49.92% of ZTS, in contrast to 42.56% held by mutual funds. Shares owned by individuals account for 27.95%. As the largest shareholder in ZTS with 8.18% of the stake, The Vanguard Group, Inc. holds 37,812,801 shares worth 37,812,801. A second-largest stockholder of ZTS, BlackRock Fund Advisors, holds 21,829,059 shares, controlling over 4.72% of the firm’s shares. SSgA Funds Management, Inc. is the third largest shareholder in ZTS, holding 19,630,557 shares or 4.25% stake. With a 2.80% stake in ZTS, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 12,959,822 shares are owned by the mutual fund manager. The Vanguard 500 Index Fund, which owns about 2.40% of ZTS stock, is the second-largest Mutual Fund holder. It holds 11,067,708 shares valued at 2.08 billion. American Funds Growth Fund of Ame holds 1.31% of the stake in ZTS, owning 6,055,987 shares worth 1.14 billion.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, ZTS reported revenue of $2.05B and operating income of $726.00M. The EBITDA in the recently reported quarter was $761.00M and diluted EPS was $1.12.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ZTS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With ZTS analysts setting a high price target of $260.00 and a low target of $195.00, the average target price over the next 12 months is $226.00. Based on these targets, ZTS could surge 42.28% to reach the target high and rise by 6.71% to reach the target low. Reaching the average price target will result in a growth of 23.67% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded ZTS stock several times over the past three months with 2 Buys and 2 Sells. In these transactions, 13,000 shares were bought while 13,000 shares were sold. The number of buy transactions has increased to 27 while that of sell transactions has risen to 28 over the past year. The total number of shares bought during that period was 99,889 while 74,646 shares were sold.